Infliximab Concentrations in Participants with Moderate to Severe COVID-19

被引：1
|
作者：
Balevic, Stephen J. [1 ,2 ,8 ,9 ]
Dandachi, Dima [3 ]
Dixon, Danielle [4 ]
Hoetelmans, Richard M. W. [5 ]
Bozzette, Sam [6 ]
Mccarthy, Matthew W. [7 ]
机构：
[1] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[3] Univ Missouri Columbia, Columbia, MO USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
[5] Janssen Infect Dis BVBA, Beerse, Belgium
[6] Natl Ctr Advancing Translat Sci, Bethesda, MD USA
[7] Weill Cornell Med, New York, NY USA
[8] Duke Univ, Dept Med, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
[9] Duke Univ, Dept Pediat, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 64卷 / 04期
关键词：
COVID-19; infliximab; pharmacokinetics;
D O I：
10.1002/jcph.2388
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：490 / 491
页数：2
相关论文
共 50 条
  • [31] Altered platelet and coagulation function in moderate-to-severe COVID-19
    Rustem I. Litvinov
    Natalia G. Evtugina
    Alina D. Peshkova
    Svetlana I. Safiullina
    Izabella A. Andrianova
    Alina I. Khabirova
    Chandrasekaran Nagaswami
    Rafael R. Khismatullin
    Svetlana S. Sannikova
    John W. Weisel
    [J]. Scientific Reports, 11
  • [32] Predictive factors for disease progression in moderate to severe COVID-19 patients
    Boubaker, Nouha
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Belkhir, Safa
    Ferchichi, Mariem
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Clinical Outcomes and Prevalence of Sarcopenia in Patients with Moderate to Severe COVID-19
    Yamamoto, Shuhei
    Sakai, Yasunari
    Matsumori, Keiji
    Osawa, Ryuji
    Ito, Shun
    Tsukakoshi, Daichi
    Ohno, Tomoki
    Ohta, Hiroaki
    Ichiyama, Takashi
    Komatsu, Masamichi
    Wada, Yosuke
    Hanaoka, Masayuki
    Ikegami, Shota
    Horiuchi, Hiroshi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [34] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [35] Severe Covid-19
    Berlin, David A.
    Gulick, Roy M.
    Martinez, Fernando J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2451 - 2460
  • [36] Paying Participants in COVID-19 Trials
    Largent, Emily A.
    Lynch, Holly Fernandez
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (03): : 356 - 361
  • [37] Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit
    Farrokhpour, Mohsen
    Rezaie, Nader
    Moradi, Najmeh
    Rad, Fatemeh Ghaffari
    Izadi, Shirin
    Azimi, Mehdi
    Zamani, Farhad
    Izadi, Shahrokh
    Ranjbar, Mitra
    Makiani, Mahin Jamshidi
    Laali, Azadeh
    Roham, Maryam
    Yadollahzadeh, Mahdi
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (02) : 139 - 143
  • [38] Intrapartum Management of Moderate to Severe COVID-19: an Evidence-Based Update
    Kelly Albrecht
    Mary Catherine Tolcher
    [J]. Current Obstetrics and Gynecology Reports, 2023, 12 (3) : 165 - 172
  • [39] Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients
    Sobel, Jonathan A.
    Levy, Jeremy
    Almog, Ronit
    Reiner-Benaim, Anat
    Miller, Asaf
    Eytan, Danny
    Behar, Joachim A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [40] Mortality and Survival Factors in Patients with Moderate and Severe Pneumonia Due to COVID-19
    Galindo-Oseguera, Evelyn
    Pinto-Almazan, Rodolfo
    Arellano-Ramirez, Alfredo
    Gasca-Lopez, Gilberto Adrian
    Ocharan-Hernandez, Maria Esther
    Calzada-Mendoza, Claudia C.
    Castillo-Cruz, Juan
    Martinez-Herrera, Erick
    [J]. HEALTHCARE, 2023, 11 (07)
12345